title: Adult coats' disease successfully managed with the dexamethasone intravitreal implant (ozurdex®) combined with retinal photocoagulation.
abstract: OBJECTIVE
  To report a case of Coats' disease managed with the dexamethasone intravitreal implant Ozurdex(®) (Allergan, Inc., Irvine, Calif., USA) combined with retinal photocoagulation.
  
  
  METHODS
  A 46-year-old female with 20/200 visual acuity was diagnosed with Coats' disease with secondary retinal vasoproliferative tumor. An initial approach was performed with an intravitreal injection of the sustained-release dexamethasone implant Ozurdex. After reattachment of the retina, the telangiectatic vessels were treated with laser photocoagulation.
  
  
  RESULTS
  The patient's visual acuity improved to 20/25 after the intravitreal Ozurdex. No further recurrences of exudation were evident through the 12-month follow-up.
  
  
  CONCLUSIONS
  Ozurdex may be an effective initial therapeutic approach for Coats' disease with immediate anatomical response and visual improvement.
authors.affiliation: Department of Ophthalmology, University and Polytechnic Hospital La Fe, Valencia, Spain.
authors.forename: Sebastián
authors.initials: S
authors.lastname: Martínez-Castillo
authors.forename: Roberto
authors.initials: R
authors.lastname: Gallego-Pinazo
authors.forename: Rosa
authors.initials: R
authors.lastname: Dolz-Marco
authors.forename: Cristina
authors.initials: C
authors.lastname: Marín-Lambíes
authors.forename: Manuel
authors.initials: M
authors.lastname: Díaz-Llopis